SCHEMBL8304360

SCHEMBL8304360

C(=NOCCOC1CCCCO1)c1ccc2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.46
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.36
CYP1A2 P05177 1/20 0.36
HPGD P15428 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA1 Q13131 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36
MAPT P10636 2/20 0.36
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
F2R P25116 2/20 0.34
HTT P42858 1/20 0.34
ALOX5 P09917 1/20 0.34
MET P08581 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309572 0.81 KDM4C (0.46) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL8307843 0.81 KDM4C (0.52) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3076916 0.80 KDM4C (0.50) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3076918 0.80 KDM4C (0.50) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3083557 0.79 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3083554 0.79 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL8308456 0.77 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3881210 0.75 KDM4C (0.49) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8304494 0.72 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8305368 0.72 NPC1 (0.57) NPC1RAB9AL3MBTL1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed